Rosalind Advisors, Inc. Hedge Fund

CIK: 0001622627 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $210,890 (100.0% shares, 0.0% debt)

Holdings (37)

DCTH DELCATH SYS INC 15.6%
Value ($000) $33,004 Shares 3,300,389 Est. Cost $6.89 Unrealized +102.4%
FENC FENNEC PHARMACEUTICALS INC 8.1%
Value ($000) $16,979 Shares 2,045,644 Est. Cost $5.68 Unrealized +20.5%
CYTK CYTOKINETICS INC 6.3%
Value ($000) $13,216 Shares 400,000 Est. Cost $34.78 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 5.4%
Value ($000) $11,310 Shares 1,218,700 Est. Cost $7.23 Unrealized +8.2%
IDYA IDEAYA BIOSCIENCES INC 5.1%
Value ($000) $10,744 Shares 511,132 Est. Cost $21.31 Unrealized -9.9%
XERS XERIS BIOPHARMA HOLDINGS INC 4.8%
Value ($000) $10,067 Shares 2,155,594 Est. Cost $1.86 Unrealized +146.1%
VRDN VIRIDIAN THERAPEUTICS INC 4.6%
Value ($000) $9,786 Shares 700,000 Est. Cost $16.51 Unrealized -17.8%
VERONA PHARMA PLC 4.5%
Value ($000) $9,458 Shares 100,000 Est. Cost $20.69 Unrealized
VSTM VERASTEM INC 4.0%
Value ($000) $8,481 Shares 2,043,563 Est. Cost $5.37 Unrealized +16.6%
REPL REPLIMUNE GROUP INC 4.0%
Value ($000) $8,361 Shares 900,000 Est. Cost $12.11 Unrealized -27.9%
MDWD MEDIWOUND LTD 3.7%
Value ($000) $7,885 Shares 407,061 Est. Cost $11.00 Unrealized +71.3%
MYO MYOMO INC 3.7%
Value ($000) $7,767 Shares 3,595,788 Est. Cost $3.20 Unrealized +13.3%
RZLT REZOLUTE INC 3.7%
Value ($000) $7,766 Shares 1,741,211 Est. Cost $3.71 Unrealized 0.0%
URGN UROGEN PHARMA LTD 3.5%
Value ($000) $7,430 Shares 542,366 Est. Cost $11.86 Unrealized -19.1%
HELP CYBIN INC 3.2%
Value ($000) $6,804 Shares 810,918 Est. Cost $10.16 Unrealized -28.4%
SVRA SAVARA INC 2.9%
Value ($000) $6,053 Shares 2,654,944 Est. Cost $3.49 Unrealized -22.0%
NSPR INSPIREMD INC 2.5%
Value ($000) $5,196 Shares 2,289,099 Est. Cost $2.49 Unrealized +0.1%
CGON CG ONCOLOGY INC 2.4%
Value ($000) $5,017 Shares 192,974 Est. Cost $24.10 Unrealized 0.0%
PROF PROFOUND MED CORP 1.9%
Value ($000) $4,084 Shares 692,185 Est. Cost $8.96 Unrealized -41.0%
PHVS PHARVARIS N V 1.9%
Value ($000) $3,936 Shares 223,627 Est. Cost $16.87 Unrealized -4.5%
PYPD POLYPID LTD 1.6%
Value ($000) $3,443 Shares 975,462 Est. Cost $4.49 Unrealized -34.7%
MIND MEDICINE MINDMED INC 1.3%
Value ($000) $2,726 Shares 420,000 Est. Cost $5.85 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 0.8%
Value ($000) $1,783 Shares 157,725 Est. Cost $9.48 Unrealized +29.0%
INMUNE BIO INC 0.8%
Value ($000) $1,764 Shares 1,033,200 Est. Cost Unrealized
TRVI TREVI THERAPEUTICS INC 0.8%
Value ($000) $1,641 Shares 300,000 Est. Cost $2.31 Unrealized +169.5%
CMPS COMPASS PATHWAYS PLC 0.6%
Value ($000) $1,351 Shares 482,651 Est. Cost $7.79 Unrealized
TLPH TALPHERA INC 0.4%
Value ($000) $922 Shares 2,003,939 Est. Cost $0.62 Unrealized -19.3%
BFRI BIOFRONTERA INC 0.3%
Value ($000) $695 Shares 976,448 Est. Cost $1.04 Unrealized -32.7%
UROGEN PHARMA LTD 0.3%
Value ($000) $600 Shares 100,000 Est. Cost Unrealized
KURA KURA ONCOLOGY INC 0.3%
Value ($000) $577 Shares 100,000 Est. Cost $7.79 Unrealized -21.4%
SPDR SERIES TRUST 0.3%
Value ($000) $534 Shares 550,000 Est. Cost Unrealized
REPLIMUNE GROUP INC 0.2%
Value ($000) $516 Shares 231,800 Est. Cost Unrealized
SPDR S&P 500 ETF TR 0.2%
Value ($000) $433 Shares 250,000 Est. Cost Unrealized
ATYR PHARMA INC 0.1%
Value ($000) $271 Shares 223,000 Est. Cost Unrealized
OVID OVID THERAPEUTICS INC 0.1%
Value ($000) $165 Shares 500,000 Est. Cost $0.30 Unrealized 0.0%
IDEAYA BIOSCIENCES INC 0.0%
Value ($000) $68 Shares 20,000 Est. Cost Unrealized
CRINETICS PHARMACEUTICALS IN 0.0%
Value ($000) $58 Shares 52,700 Est. Cost Unrealized